Adrenal insufficiency after glucocorticoid withdrawal in children with rheumatic diseases

Acta Paediatrica
Benedikt M HuberChrista E Flück

Abstract

Glucocorticoids (GCs) are often used for the treatment of rheumatic disorders. However, doses are prescribed, which may suppress the hypothalamic-pituitary-adrenal (HPA) axis. After GC withdrawal, recovery of the HPA axis may be delayed putting the patient at risk for adrenal insufficiency. We assessed adrenal function and factors influencing adrenal responsiveness after termination of GC therapy in paediatric patients with rheumatic diseases. Nineteen patients aged 2-15 years were followed clinically, and adrenal function was tested by low-dose adrenocorticotropic hormone test 1 month after GC withdrawal. In case of adrenal insufficiency by test, re-assessment was performed after 6 and 18 months. No signs or symptoms of adrenal insufficiency occurred in any of the patients during and after GC withdrawal. Biochemical examination revealed adrenal insufficiency in 32% (6/19) at 4 weeks and in 11% (2/19) at 20 months after GC withdrawal. In conclusion, current strategies to withdraw GC from paediatric patients with rheumatic diseases are safe. Routine adrenal function testing after GC therapy and withdrawal may not be needed considering the low risk but high number of patients treated with GCs. Nevertheless, awareness of the poten...Continue Reading

References

Oct 17, 1996·The New England Journal of Medicine·W Oelkers
Jan 15, 1998·The New England Journal of Medicine·B S McEwen
Mar 23, 1999·Archives of Disease in Childhood·J C AgwuC G Brook
Oct 12, 1999·JAMA : the Journal of the American Medical Association·A S Krasner
Jul 13, 2000·The Journal of Pediatrics·E I FelnerB A Dickson
Jul 26, 2002·The Journal of Steroid Biochemistry and Molecular Biology·R H DeRijkE R de Kloet
Feb 21, 2003·The New England Journal of Medicine·Mark S Cooper, Paul M Stewart
May 23, 2003·The New England Journal of Medicine·Djillali AnnaneCharles L Sprung
Jun 6, 2003·Lancet·Wiebke Arlt, Bruno Allolio
Aug 23, 2003·Lancet·Alex Poteliakhoff
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Cristiane de Freitas CunhaFrancisca Lee Finch
Aug 4, 2004·The Journal of Pediatrics·Heidi L GassnerWalter L Miller
Jan 24, 2007·Pediatrics·Dorothy I ShulmanUNKNOWN Lawson Wilkins Drug and Therapeutics Committee
Sep 11, 2007·Pediatric Blood & Cancer·Silvia EinaudiGuido Pastore
Mar 1, 2008·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Michael Magnotti, Mona Shimshi
Apr 29, 2008·Current Opinion in Endocrinology, Diabetes, and Obesity·Gabriel Dickstein, Leonard Saiegh
May 29, 2009·The New England Journal of Medicine·Stefan R Bornstein
Aug 21, 2009·The New England Journal of Medicine·David A Kaufman

❮ Previous
Next ❯

Citations

Jun 29, 2013·European Journal of Internal Medicine·Stina DinsenUlla Feldt-Rasmussen
Jul 25, 2015·Clinical Endocrinology·Lisanne C C J SmansPierre M J Zelissen
Oct 22, 2016·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Alexandra AhmetJanice L Barkey
Mar 30, 2017·Lung·Robert P BaughmanElyse E Lower
Mar 23, 2017·Archives of Disease in Childhood·Ellen B GoldbloomAlexandra Ahmet
Dec 22, 2017·Revista da Associação Médica Brasileira·Cristina B BarraIvani Novato Silva
Jan 2, 2021·The Senior Care Pharmacist·Tsuhua Susan Chen, Shilun David Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.